Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates-Reference-Cited by-同舟云学术

Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates

Published:2022-11 Issue: Volume:627 Page:122220
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Négrier Laura,Martin Mena Anthony,Lebuffe Gilles,Maury Éric,Gaudy Romain,Degand Flavie,Thibaut Manon,Carta Natacha,Odou Pascal,Genay Stéphanie,Décaudin Bertrand

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference70 articles.

1. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

2. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC;Arzuaga;Biomed. Chromatogr.,2005

3. An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses;Bartels;Anesth. Analg.,2009

4. Base de données publique des médicaments, 2022. Notice patient - VANCOMYCINE VIATRIS 1000 mg, poudre pour solution à diluer pour perfusion [WWW Document]. URL https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=69553715&typedoc=N/ (accessed 6.24.22).

5. Clinical implications of intravenous drug incompatibilities in critically ill patients;Benlabed;Anaesth. Crit. Care Pain Med.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility;Pharmaceutics;2023-08-01